Clear Cell Renal Cell Carcinoma (ccRCC)

Also known as: Renal Cell Carcinoma With Clear Cell Histology / Clear Cell Renal Cell Carcinoma / Clear Cell Renal Carcinoma / Clear Cell RCC / Renal clear cell carcinoma / Clear cell renal cell carcinoma (morphologic abnormality) / Hypernephroma (disorder) / Hypernephroma / Renal cell carcinoma (morphologic abnormality) / Clear cell carcinoma of kidney (disorder) / Clear cell carcinoma of the kidney

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00112	Bevacizumab	0	Unknown Status	1
DB09331	Daratumumab	0	Active Not Recruiting	1
DB05094	Enzalutamide	0	Terminated	1
DB08899	Enzalutamide	0	Terminated	1
DB06186	Ipilimumab	0	Unknown Status	1
DB09035	Nivolumab	0	Unknown Status	1
DB11771	Tremelimumab	0	Completed	1
DB12001	Abemaciclib	1	Recruiting	1
DB11595	Atezolizumab	1	Recruiting	1
DB15463	Belzutifan	1	Active Not Recruiting	1
DB15463	Belzutifan	1	Recruiting	1
DB00112	Bevacizumab	1	Completed	1
DB08875	Cabozantinib	1	Active Not Recruiting	1
DB00531	Cyclophosphamide	1	Terminated	1
DB06186	Ipilimumab	1	Active Not Recruiting	2
DB09035	Nivolumab	1	Active Not Recruiting	3
DB06132	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Completed	1
DB09035	Nivolumab	1	Terminated	1
DB16055	PT-2385	1	Active Not Recruiting	1
DB16055	PT-2385	1	Recruiting	1
DB09037	Pembrolizumab	1	Recruiting	2
DB15036	Sitravatinib	1	Active Not Recruiting	1
DB01268	Sunitinib	1	Completed	3
DB00062	Albumin human	1 / 2	Recruiting	1
DB00041	Aldesleukin	1 / 2	Active Not Recruiting	1
DB06626	Axitinib	1 / 2	Completed	1
DB06626	Axitinib	1 / 2	Recruiting	1
DB00112	Bevacizumab	1 / 2	Completed	5
DB00112	Bevacizumab	1 / 2	Recruiting	1
DB08875	Cabozantinib	1 / 2	Active Not Recruiting	1
DB00091	Cyclosporine	1 / 2	Completed	2
DB11714	Durvalumab	1 / 2	Active Not Recruiting	1
DB11714	Durvalumab	1 / 2	Completed	1
DB11841	Entinostat	1 / 2	Active Not Recruiting	1
DB00530	Erlotinib	1 / 2	Completed	1
DB01590	Everolimus	1 / 2	Terminated	1
DB01073	Fludarabine	1 / 2	Completed	2
DB11918	Guadecitabine	1 / 2	Active Not Recruiting	1
DB14865	Human interleukin-2	1 / 2	Recruiting	1
DB00619	Imatinib	1 / 2	Completed	1
DB15768	MEDI0680	1 / 2	Completed	1
DB00688	Mycophenolate mofetil	1 / 2	Completed	2
DB09035	Nivolumab	1 / 2	Active Not Recruiting	1
DB09035	Nivolumab	1 / 2	Completed	3
DB09035	Nivolumab	1 / 2	Terminated	1
DB06603	Panobinostat	1 / 2	Terminated	1
DB06589	Pazopanib	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Completed	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB11142	Selenomethionine	1 / 2	Recruiting	1
DB00877	Sirolimus	1 / 2	Completed	1
DB15036	Sitravatinib	1 / 2	Completed	1
DB00398	Sorafenib	1 / 2	Completed	1
DB11760	Talazoparib	1 / 2	Terminated	1
DB15232	Telaglenastat	1 / 2	Completed	1
DB15232	Telaglenastat	1 / 2	Terminated	1
DB06287	Temsirolimus	1 / 2	Completed	1
DB02546	Vorinostat	1 / 2	Completed	1
DB00126	Ascorbic acid	2	Terminated	1
DB11945	Avelumab	2	Terminated	1
DB11945	Avelumab	2	Withdrawn	1
DB06626	Axitinib	2	Active Not Recruiting	1
DB06626	Axitinib	2	Completed	1
DB06626	Axitinib	2	Not Yet Recruiting	3
DB06626	Axitinib	2	Recruiting	1
DB06626	Axitinib	2	Unknown Status	2
DB15463	Belzutifan	2	Active Not Recruiting	1
DB11105	Benzalkonium	2	Completed	1
DB11105	Benzalkonium	2	Terminated	1
DB00112	Bevacizumab	2	Completed	2
DB08875	Cabozantinib	2	Active Not Recruiting	2
DB08875	Cabozantinib	2	Completed	1
DB08875	Cabozantinib	2	Not Yet Recruiting	1
DB08875	Cabozantinib	2	Recruiting	1
DB16680	Cadonilimab	2	Not Yet Recruiting	1
DB14776	Camrelizumab	2	Unknown Status	1
DB00958	Carboplatin	2	Completed	1
DB06322	Carotuximab	2	Completed	1
DB04849	Cediranib	2	Terminated	1
DB14917	Ceralasertib	2	Recruiting	1
DB00531	Cyclophosphamide	2	Completed	1
DB00970	Dactinomycin	2	Completed	1
DB06643	Denosumab	2	Recruiting	1
DB15627	Dostarlimab	2	Recruiting	1
DB05928	Dovitinib	2	Unknown Status	1
DB00997	Doxorubicin	2	Completed	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB11714	Durvalumab	2	Recruiting	1
DB00773	Etoposide	2	Completed	1
DB01590	Everolimus	2	Completed	3
DB05304	Girentuximab	2	Not Yet Recruiting	1
DB05304	Girentuximab	2	Recruiting	1
DB05258	Interferon alfa	2	Terminated	1
DB00034	Interferon alfa-2a	2	Terminated	1
DB00105	Interferon alfa-2b	2	Completed	2
DB00105	Interferon alfa-2b	2	Terminated	1
DB00018	Interferon alfa-n3	2	Terminated	1
DB17467	Interleukin-15, human recombinant	2	Terminated	1
DB08824	Ioflupane I-123	2	Terminated	1
DB06186	Ipilimumab	2	Withdrawn	1
DB00762	Irinotecan	2	Completed	1
DB16208	Ivuxolimab	2	Active Not Recruiting	1
DB04845	Ixabepilone	2	Completed	1
DB13982	Lutetium Lu-177	2	Not Yet Recruiting	1
DB13982	Lutetium Lu-177	2	Recruiting	1
DB11740	MK-1775	2	Active Not Recruiting	1
DB14123	Menthol	2	Completed	1
DB11813	Mipsagargin	2	Completed	1
DB11793	Niraparib	2	Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Not Yet Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB09035	Nivolumab	2	Withdrawn	1
DB09074	Olaparib	2	Recruiting	1
DB16055	PT-2385	2	Active Not Recruiting	1
DB03010	Patupilone	2	Completed	1
DB06589	Pazopanib	2	Completed	3
DB06589	Pazopanib	2	Terminated	1
DB09037	Pembrolizumab	2	Not Yet Recruiting	1
DB09037	Pembrolizumab	2	Recruiting	2
DB11870	RG-4733	2	Completed	1
DB12048	Savolitinib	2	Active Not Recruiting	1
DB15765	Sintilimab	2	Not Yet Recruiting	1
DB00877	Sirolimus	2	Completed	1
DB15036	Sitravatinib	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Completed	3
DB00398	Sorafenib	2	Terminated	2
DB01268	Sunitinib	2	Completed	3
DB01268	Sunitinib	2	Unknown Status	2
DB01268	Sunitinib	2	Withdrawn	1
DB05465	Tandutinib	2	Completed	1
DB15232	Telaglenastat	2	Completed	1
DB06287	Temsirolimus	2	Completed	1
DB11771	Tremelimumab	2	Active Not Recruiting	1
DB00541	Vincristine	2	Completed	1
DB06626	Axitinib	3	Terminated	1
DB15463	Belzutifan	3	Recruiting	1
DB00112	Bevacizumab	3	Terminated	1
DB08875	Cabozantinib	3	Recruiting	1
DB01590	Everolimus	3	Terminated	1
DB06205	Hyaluronidase (human recombinant)	3	Recruiting	1
DB06186	Ipilimumab	3	Recruiting	1
DB09035	Nivolumab	3	Recruiting	2
DB06589	Pazopanib	3	Active Not Recruiting	1
DB09037	Pembrolizumab	3	Recruiting	1
DB00398	Sorafenib	3	Completed	1
DB01268	Sunitinib	3	Completed	1
DB00112	Bevacizumab	Not Available	Completed	1
DB00091	Cyclosporine	Not Available	Completed	1
DB01073	Fludarabine	Not Available	Completed	1
DB09502	Fludeoxyglucose (18F)	Not Available	Completed	1
DB05304	Girentuximab	Not Available	Completed	1
DB11659	Indium	Not Available	Completed	1
DB00688	Mycophenolate mofetil	Not Available	Completed	1
DB06589	Pazopanib	Not Available	Terminated	1
DB06589	Pazopanib	Not Available	Withdrawn	1
DB00398	Sorafenib	Not Available	Completed	1
DB17459	Therapeutic allogeneic lymphocytes	Not Available	Completed	1